康哲药业涨超5% 合作伙伴新元素药业抗痛风创新药ABP-671全球IIb/III期临床取得积极结果

港美通
Sep 11

9月11日14:40,康哲药业(00867)大幅上涨5.02%,该股报15.070港元,最高报15.070港元,最低报13.560港元,成交量1258.42万股,成交额18398.86万港元。消息面上,杭州新元素药业股份有限公司近日宣布,ABP-671用于治疗痛风的全球IIb/III期临床试验取得了十分积极的结果。该项临床试验达到所有主要治疗终点及次要治疗终点,同时ABP-671展现出良好的安全性...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10